Literature DB >> 18177481

AMP-activated protein kinase activation as a strategy for protecting vascular endothelial function.

Ming-Hui Zou1, Yong Wu.   

Abstract

1. AMP-activated protein kinase (AMPK) is a serine/threonine protein kinase involved in the regulation of cellular and organismal metabolism. AMPK has a heterotrimeric structure, consisting of a catalytic alpha-subunit and regulatory beta- and gamma-subunits, each of which has two or more isoforms that are differentially expressed in various tissues and that arise from distinct genes. The AMPK system acts as a sensor of cellular energy status that is conserved in all eukaryotic cells. In addition, AMPK is activated by physiological stimuli and oxidants. 2. The importance of AMPK in cardiovascular functions is best demonstrated by recent studies showing that widely used drugs, including statins, metformin and rosiglitazone, execute cardiovascular protective effects at least partly through the activation of AMPK. As a consequence, AMPK has been proposed as a candidate target for therapeutic intervention in the treatment of both Type 2 diabetes and metabolic syndrome owing to its central role in the regulation of energy balance; it may also have a role in weight control. 3. In the present brief review, we summarize the recent progress of AMPK signalling and regulation focusing on vascular endothelial cells. We further hypothesize that AMPK is a dual sensor for energy and redox status within a cell and AMPK may be a therapeutic target for protecting vascular endothelial function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18177481      PMCID: PMC2869205          DOI: 10.1111/j.1440-1681.2007.04851.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  113 in total

1.  Regulation of 5'-AMP-activated protein kinase activity by the noncatalytic beta and gamma subunits.

Authors:  J R Dyck; G Gao; J Widmer; D Stapleton; C S Fernandez; B E Kemp; L A Witters
Journal:  J Biol Chem       Date:  1996-07-26       Impact factor: 5.157

2.  The alpha1 and alpha2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro.

Authors:  A Woods; I Salt; J Scott; D G Hardie; D Carling
Journal:  FEBS Lett       Date:  1996-11-18       Impact factor: 4.124

3.  Biochemical characterization and deletion analysis of recombinant human protein phosphatase 2C alpha.

Authors:  A E Marley; J E Sullivan; D Carling; W M Abbott; G J Smith; I W Taylor; F Carey; R K Beri
Journal:  Biochem J       Date:  1996-12-15       Impact factor: 3.857

4.  Activation of nuclear factor-kappaB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C.

Authors:  G M Pieper
Journal:  J Cardiovasc Pharmacol       Date:  1997-10       Impact factor: 3.105

5.  5'-AMP activates the AMP-activated protein kinase cascade, and Ca2+/calmodulin activates the calmodulin-dependent protein kinase I cascade, via three independent mechanisms.

Authors:  S A Hawley; M A Selbert; E G Goldstein; A M Edelman; D Carling; D G Hardie
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

6.  Protein phosphatase type 2C active at physiological Mg2+: stimulation by unsaturated fatty acids.

Authors:  S Klumpp; D Selke; J Hermesmeier
Journal:  FEBS Lett       Date:  1998-10-23       Impact factor: 4.124

7.  AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the alpha2 isoform.

Authors:  I Salt; J W Celler; S A Hawley; A Prescott; A Woods; D Carling; D G Hardie
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

8.  5'-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C alpha and native bovine protein phosphatase-2AC.

Authors:  S P Davies; N R Helps; P T Cohen; D G Hardie
Journal:  FEBS Lett       Date:  1995-12-27       Impact factor: 4.124

9.  Mammalian AMP-activated protein kinase subfamily.

Authors:  D Stapleton; K I Mitchelhill; G Gao; J Widmer; B J Michell; T Teh; C M House; C S Fernandez; T Cox; L A Witters; B E Kemp
Journal:  J Biol Chem       Date:  1996-01-12       Impact factor: 5.157

Review 10.  Signalling by protein kinase C isoforms in the heart.

Authors:  M Pucéat; G Vassort
Journal:  Mol Cell Biochem       Date:  1996 Apr 12-26       Impact factor: 3.396

View more
  47 in total

1.  Normal IgG downregulates the intracellular superoxide level and attenuates migration and permeability in human aortic endothelial cells isolated from a hypertensive patient.

Authors:  Xiuqing Wang; Qianyu Wang; Zhongjie Sun
Journal:  Hypertension       Date:  2012-07-09       Impact factor: 10.190

2.  Activation of AMPK stimulates heme oxygenase-1 gene expression and human endothelial cell survival.

Authors:  Xiao-ming Liu; Kelly J Peyton; Ahmad R Shebib; Hong Wang; Ronald J Korthuis; William Durante
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-29       Impact factor: 4.733

Review 3.  Molecular insights and therapeutic targets for diabetic endothelial dysfunction.

Authors:  Jian Xu; Ming-Hui Zou
Journal:  Circulation       Date:  2009-09-29       Impact factor: 29.690

4.  Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed mice.

Authors:  Kristen A Baltgalvis; Kathy White; Wei Li; Mark D Claypool; Wayne Lang; Raniel Alcantara; Baljit K Singh; Annabelle M Friera; John McLaughlin; Derek Hansen; Kelly McCaughey; Henry Nguyen; Ira J Smith; Guillermo Godinez; Simon J Shaw; Dane Goff; Rajinder Singh; Vadim Markovtsov; Tian-Qiang Sun; Yonchu Jenkins; Gerald Uy; Yingwu Li; Alison Pan; Tarikere Gururaja; David Lau; Gary Park; Yasumichi Hitoshi; Donald G Payan; Todd M Kinsella
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-21       Impact factor: 4.733

Review 5.  Molecular mechanisms underlying the activation of eNOS.

Authors:  Ingrid Fleming
Journal:  Pflugers Arch       Date:  2009-12-13       Impact factor: 3.657

Review 6.  Effects of AMP-activated protein kinase in cerebral ischemia.

Authors:  Jun Li; Louise D McCullough
Journal:  J Cereb Blood Flow Metab       Date:  2009-12-16       Impact factor: 6.200

Review 7.  The use of metformin in type 1 diabetes: a systematic review of efficacy.

Authors:  S Vella; L Buetow; P Royle; S Livingstone; H M Colhoun; J R Petrie
Journal:  Diabetologia       Date:  2010-01-08       Impact factor: 10.122

8.  Activation of SIRT1 Attenuates Klotho Deficiency-Induced Arterial Stiffness and Hypertension by Enhancing AMP-Activated Protein Kinase Activity.

Authors:  Diansa Gao; Zhong Zuo; Jing Tian; Quaisar Ali; Yi Lin; Han Lei; Zhongjie Sun
Journal:  Hypertension       Date:  2016-09-12       Impact factor: 10.190

9.  Activation of AMP-activated protein kinase inhibits oxidized LDL-triggered endoplasmic reticulum stress in vivo.

Authors:  Yunzhou Dong; Miao Zhang; Shuangxi Wang; Bin Liang; Zhengxing Zhao; Chao Liu; Mingyuan Wu; Hyoung Chul Choi; Timothy J Lyons; Ming-Hui Zou
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

10.  In vivo activation of AMP-activated protein kinase attenuates diabetes-enhanced degradation of GTP cyclohydrolase I.

Authors:  Shuangxi Wang; Jian Xu; Ping Song; Benoit Viollet; Ming-Hui Zou
Journal:  Diabetes       Date:  2009-06-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.